Contact
searchSearch
HMP Global
Accetta
Videos
Leveraging Digital Innovation to Enhance Patient Care in Specialty Pharmacy
05/30/2025
Lucille Accetta, RPh, MPH, MBA
Lucille Accetta, RPh, MPH, MBA, chief pharmacy officer and head of CVS Specialty Operations, highlights how CVS Specialty combines digital innovation with clinical expertise to personalize care, streamline access, improve adherence, and...
Lucille Accetta, RPh, MPH, MBA, chief pharmacy officer and head of CVS Specialty Operations, highlights how CVS Specialty combines digital innovation with clinical expertise to personalize care, streamline access, improve adherence, and...
Lucille Accetta, RPh, MPH, MBA,...
05/30/2025
First Report Managed Care
John Colaizzi, PharmD
Interview
Improving Patient Outcomes With Specialty Pharmacies Near Centers of Excellence and Providers
05/29/2025
John L. Colaizzi, Jr., PharmD
Discover how strategically locating specialty pharmacies near Centers of Excellence and key opinion leaders is transforming access, accelerating therapy initiation, and improving outcomes for patients, including those with rare and complex...
Discover how strategically locating specialty pharmacies near Centers of Excellence and key opinion leaders is transforming access, accelerating therapy initiation, and improving outcomes for patients, including those with rare and complex...
Discover how strategically...
05/29/2025
First Report Managed Care
Canavan
Videos
Cost Containment in 2025: Effective Approaches to Specialty Drug Management
05/29/2025
Josh Canavan, PharmD
In this interview, Josh Canavan, PharmD, head of pharmacy at RazorMetrics, discusses rising specialty drug costs, payer challenges in biosimilar adoption, the importance of seamless prescriber engagement, data-driven approaches to formulary...
In this interview, Josh Canavan, PharmD, head of pharmacy at RazorMetrics, discusses rising specialty drug costs, payer challenges in biosimilar adoption, the importance of seamless prescriber engagement, data-driven approaches to formulary...
In this interview, Josh Canavan,...
05/29/2025
First Report Managed Care
Conference Coverage
Aligning Stakeholders in Oncology’s Evolving Drug Distribution Landscape
05/28/2025
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACC
A guest expert from Asembia 2025 explores how reimagining limited drug distribution models in oncology can eliminate care fragmentation, enhance patient outcomes, and foster stronger collaboration among providers, pharmacies, payers, and...
A guest expert from Asembia 2025 explores how reimagining limited drug distribution models in oncology can eliminate care fragmentation, enhance patient outcomes, and foster stronger collaboration among providers, pharmacies, payers, and...
A guest expert from Asembia 2025...
05/28/2025
First Report Managed Care
Bedford Headshot
Videos
Adapting to Market Shifts: Specialty Distribution Strategies for Emerging Therapies
05/23/2025
Natalie Bedford
In this interview, Natalie Bedford, senior vice president of US pharmaceutical distribution services at McKesson, discusses how specialty distributors provide strategic value beyond logistics by offering regulatory expertise, advanced...
In this interview, Natalie Bedford, senior vice president of US pharmaceutical distribution services at McKesson, discusses how specialty distributors provide strategic value beyond logistics by offering regulatory expertise, advanced...
In this interview, Natalie...
05/23/2025
First Report Managed Care
Conference Coverage
Navigating MFP Implementation: Stakeholders Weigh IRA Challenges at Asembia 2025
05/22/2025
Juliet Gallagher
At Asembia 2025, industry experts from Cencora gathered to dissect the pressing challenges and evolving implementation framework of the Inflation Reduction Act’s (IRA) Maximum Fair Price (MFP) provision.
At Asembia 2025, industry experts from Cencora gathered to dissect the pressing challenges and evolving implementation framework of the Inflation Reduction Act’s (IRA) Maximum Fair Price (MFP) provision.
At Asembia 2025, industry...
05/22/2025
First Report Managed Care
Dee Chaudary, MBA
Videos
Best Practices for Enhancing Patient Services Programs for Rare Diseases
05/20/2025
Dee Chaudhary, MBA
Dee Chaudhary provides insights from her Asembia 2025 presentation on the strategic design of patient services programs and how they benefit care delivery and outcomes in rare diseases.
Dee Chaudhary provides insights from her Asembia 2025 presentation on the strategic design of patient services programs and how they benefit care delivery and outcomes in rare diseases.
Dee Chaudhary provides insights...
05/20/2025
First Report Managed Care
JB
Interview
Reimagining Market Access in a Consolidated Health Care Landscape
05/13/2025
Jeff Berkowitz
Our guest expert and Asembia 2025 panelist pulls back the curtain on the evolving complexities of pharmaceutical market access, urging a shift from siloed strategies to data-driven, cross-functional collaboration that puts affordability and...
Our guest expert and Asembia 2025 panelist pulls back the curtain on the evolving complexities of pharmaceutical market access, urging a shift from siloed strategies to data-driven, cross-functional collaboration that puts affordability and...
Our guest expert and Asembia...
05/13/2025
First Report Managed Care
Conference Coverage
How Payers Are Responding to Specialty Drug Challenges
05/12/2025
Juliet Gallagher
At Asembia 2025, PSG presented findings from its latest "Trends in Specialty Benefit Design Report," highlighting payer strategies for managing specialty drug costs, optimizing rebate structures, and addressing challenges in biosimilar...
At Asembia 2025, PSG presented findings from its latest "Trends in Specialty Benefit Design Report," highlighting payer strategies for managing specialty drug costs, optimizing rebate structures, and addressing challenges in biosimilar...
At Asembia 2025, PSG presented...
05/12/2025
First Report Managed Care
DePinto
Videos
Expanding Access to Cell and Gene Therapies Through Innovative Pathways and Policy Reform: Asembia 2025
05/12/2025
Joe DePinto
In this interview, Joe DePinto, head of cell, gene, and advanced therapies at McKesson, discusses the evolving frameworks, policy advancements, and early commercialization strategies necessary to expand patient access to cell and gene...
In this interview, Joe DePinto, head of cell, gene, and advanced therapies at McKesson, discusses the evolving frameworks, policy advancements, and early commercialization strategies necessary to expand patient access to cell and gene...
In this interview, Joe DePinto,...
05/12/2025
First Report Managed Care
Conference Coverage
Strengthening the Specialty Pharmacy Ecosystem Through Strategic Collaboration
04/30/2025
Juliet Gallagher
In the evolving landscape of specialty pharmacy, the need for strategic collaboration between integrated delivery networks (IDNs), payers, and manufacturers has never been greater. At Asembia 2025, panelists representing health systems,...
In the evolving landscape of specialty pharmacy, the need for strategic collaboration between integrated delivery networks (IDNs), payers, and manufacturers has never been greater. At Asembia 2025, panelists representing health systems,...
In the evolving landscape of...
04/30/2025
First Report Managed Care
Conference Coverage
What Payers and Manufacturers Need to Know About IRA Implementation
04/29/2025
Juliet Gallagher
In a packed session at Asembia 2025, Brian Corvino, lead partner at Deloitte Consulting, and Blasine Penkowski, former chief strategic customer officer at Johnson & Johnson, walked attendees through key lessons from early implementation of...
In a packed session at Asembia 2025, Brian Corvino, lead partner at Deloitte Consulting, and Blasine Penkowski, former chief strategic customer officer at Johnson & Johnson, walked attendees through key lessons from early implementation of...
In a packed session at Asembia...
04/29/2025
First Report Managed Care
Conference Coverage
Strategies for Optimizing Free Drug Programs in a Changing Policy Landscape
04/29/2025
Juliet Gallagher
At Asembia 2025, experts from AcariaHealth detailed how strategic management of free drug programs can optimize outcomes for manufacturers and patients alike, while adapting to evolving regulatory and payer environments.
At Asembia 2025, experts from AcariaHealth detailed how strategic management of free drug programs can optimize outcomes for manufacturers and patients alike, while adapting to evolving regulatory and payer environments.
At Asembia 2025, experts from...
04/29/2025
First Report Managed Care
Conference Coverage
Expanding Access to Specialty Care Through Community Pharmacy: Insights From Walmart and J&J at Asembia 2025
04/29/2025
Juliet Gallagher
During Asembia 2025, leaders from Walmart and Johnson & Johnson (J&J) showcased how community-based pharmacy models are helping expand access to specialty care while positioning pharmacists as central to improving patient outcomes.
During Asembia 2025, leaders from Walmart and Johnson & Johnson (J&J) showcased how community-based pharmacy models are helping expand access to specialty care while positioning pharmacists as central to improving patient outcomes.
During Asembia 2025, leaders...
04/29/2025
First Report Managed Care
Conference Coverage
The New Reality for Payers in a Shifting Health Care Environment
04/28/2025
Juliet Gallagher
At Asembia 2025, Luke Greenwalt, vice president at IQVIA, presented a sweeping overview of the evolving health care and pharmaceutical landscape, highlighting critical trends for payers as the industry enters a period of accelerated change.
At Asembia 2025, Luke Greenwalt, vice president at IQVIA, presented a sweeping overview of the evolving health care and pharmaceutical landscape, highlighting critical trends for payers as the industry enters a period of accelerated change.
At Asembia 2025, Luke Greenwalt,...
04/28/2025
First Report Managed Care
Conference Coverage
Specialty Pharmacy Pipeline Update: Asembia 2025 Highlights
04/28/2025
Danielle Sposato
The specialty pharmaceutical market continues to expand rapidly, driven by strong innovation across therapeutic areas such as rare diseases, oncology, immunology, and neurology, with 2024 seeing the approval of several significant novel...
The specialty pharmaceutical market continues to expand rapidly, driven by strong innovation across therapeutic areas such as rare diseases, oncology, immunology, and neurology, with 2024 seeing the approval of several significant novel...
The specialty pharmaceutical...
04/28/2025
First Report Managed Care
Conference Coverage
Centering Patients Within Value-Based Care
07/30/2024
Olivia Banyon; Sean McCabe
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia Banyon and Sean McCabe discuss the concept of value-based care, patient-centered care, clinician well-being, and system workflows to improve the quality of life for patients.
Asembia 2024 speakers Olivia...
07/30/2024
First Report Managed Care
Bill McElnea
Conference Coverage
Unlocking the Value-Based Care Potential of Health System Specialty Pharmacies
07/26/2024
Bill McElnea
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill McElnea discusses the role of health system specialty pharmacies in reducing total cost of care, enhancing medication adherence, and improving outcomes under value-based care arrangements.
Asembia 2024 speaker Bill...
07/26/2024
First Report Managed Care
Interview
Enhancing Patient Services: Payer and Provider Considerations
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a...
06/28/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Alison Lum Headshot
Interview
Transforming Pharmacy Care and Drug Payment Models: Expert Insights From Asembia 2024
06/06/2024
Alison Lum, PharmD
In this interview, Alison Lum, PharmD, vice president of Pharmacy Services at Blue Shield, discussed the panel she moderated at Asembia 2024 and delved into drug payment options' challenges, including the limitations of copay cards and the...
In this interview, Alison Lum, PharmD, vice president of Pharmacy Services at Blue Shield, discussed the panel she moderated at Asembia 2024 and delved into drug payment options' challenges, including the limitations of copay cards and the...
In this interview, Alison Lum,...
06/06/2024
First Report Managed Care
Carmine DeNardo Headshot
Interview
The Evolving Landscape of Specialty Pharmacy: PROs and PROMs Insights
05/28/2024
Following Asembia 2024, an expert emphasizes the critical role of specialty pharmacies in patient care and highlights payers' increasing coverage of high-cost biologics and oncology medications, driven by value-based contracts and real-world...
Following Asembia 2024, an expert emphasizes the critical role of specialty pharmacies in patient care and highlights payers' increasing coverage of high-cost biologics and oncology medications, driven by value-based contracts and real-world...
Following Asembia 2024, an...
05/28/2024
First Report Managed Care
Joe DePinto Headshot
Conference Coverage
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Conference Coverage
Evolving Payer Strategies for Rare and Specialty Disease Management: Insights from Asembia 2024
05/20/2024
Matt Dickinson, PharmD, MBA, Alnylam Pharmaceuticals, led a panel to highlight payer strategies for managing rare and specialty disease products and how they continue to evolve based on Alnylam Pharmaceuticals’ 2023 Rare and Specialty Trend...
Matt Dickinson, PharmD, MBA, Alnylam Pharmaceuticals, led a panel to highlight payer strategies for managing rare and specialty disease products and how they continue to evolve based on Alnylam Pharmaceuticals’ 2023 Rare and Specialty Trend...
Matt Dickinson, PharmD, MBA,...
05/20/2024
First Report Managed Care
Conference Coverage
What Does Value Mean to You: Value-Based Contracting Expert Insights
05/02/2024
Danielle Sposato
A panel at Asembia 2024 delved into the complexities of value-based contracting in health care, emphasizing the need for collaboration among stakeholders to address key issues and improving access to medicines for patients.
A panel at Asembia 2024 delved into the complexities of value-based contracting in health care, emphasizing the need for collaboration among stakeholders to address key issues and improving access to medicines for patients.
A panel at Asembia 2024 delved...
05/02/2024
First Report Managed Care
Conference Coverage
Expanding Pharmacists’ Role in Providing Clinical Care: Addressing Public Health Challenges
05/02/2024
Danielle Sposato
Panelists from various backgrounds discuss the critical role of pharmacists in addressing public health challenges such as HIV/AIDS and advocating for expanded clinical care and reimbursement pathways to improve health outcomes in communities.
Panelists from various backgrounds discuss the critical role of pharmacists in addressing public health challenges such as HIV/AIDS and advocating for expanded clinical care and reimbursement pathways to improve health outcomes in communities.
Panelists from various...
05/02/2024
First Report Managed Care
Conference Coverage
Addressing Cost & Accessibility for Innovative Medicines: GLP-1s and Beyond
05/02/2024
Danielle Sposato
The rapid pace of innovation, rising costs of prescription drugs, and the need for transparency to ensure access and affordability in the pharmaceutical industry are discussed in a session at Asembia 2024.
The rapid pace of innovation, rising costs of prescription drugs, and the need for transparency to ensure access and affordability in the pharmaceutical industry are discussed in a session at Asembia 2024.
The rapid pace of innovation,...
05/02/2024
First Report Managed Care
Conference Coverage
Rare Orphan, Oncology, and Specialty Drugs in Development: Review of Therapeutic Areas, Designations, and Launch Projections
05/01/2024
Danielle Sposato
The specialty pharmacy pipeline was the subject of one of many informative sessions at the annual Asembia Summit this year. Key insights were shared about current drugs in the pipeline according to their drug designations, the phase of each...
The specialty pharmacy pipeline was the subject of one of many informative sessions at the annual Asembia Summit this year. Key insights were shared about current drugs in the pipeline according to their drug designations, the phase of each...
The specialty pharmacy pipeline...
05/01/2024
First Report Managed Care
Conference Coverage
Evolving Implications of the Inflation Reduction Act's Drug Pricing Policies
05/12/2023
Hannah Musick
Experts at Asembia's AXS23 Summit discussed upcoming changes in the Inflation Reduction Act (IRA) and how stakeholders can be strategically prepared.
Experts at Asembia's AXS23 Summit discussed upcoming changes in the Inflation Reduction Act (IRA) and how stakeholders can be strategically prepared.
Experts at Asembia's AXS23...
05/12/2023
First Report Managed Care
Conference Coverage
Navigating Specialty Legislation: Solutions for Shared Pharmacy Services
05/11/2023
Hannah Musick
Speakers at Asembia's AXS23 Summit discussed the increased demand for shared services pharmacy models, including common regulatory problems and potential solutions.
Speakers at Asembia's AXS23 Summit discussed the increased demand for shared services pharmacy models, including common regulatory problems and potential solutions.
Speakers at Asembia's AXS23...
05/11/2023
First Report Managed Care
Conference Coverage
Using Artificial Intelligence to Understand and Improve Medication Nonadherence
05/11/2023
Hannah Musick
A panel discussed the results of an experiment using artificial intelligence and machine learning to identify and improve interventions for patients who were nonadherent to their medications.
A panel discussed the results of an experiment using artificial intelligence and machine learning to identify and improve interventions for patients who were nonadherent to their medications.
A panel discussed the results of...
05/11/2023
First Report Managed Care
Conference Coverage
Payer Trends in Rare Disease Management, Therapeutic Coverage
05/04/2023
Edan Stanley
In a session at Asembia’s AXS23 Summit, a panel discussed payer trends in rare disease management and offered different perspectives on how the data from a recent report can be leveraged to improve outcomes.
In a session at Asembia’s AXS23 Summit, a panel discussed payer trends in rare disease management and offered different perspectives on how the data from a recent report can be leveraged to improve outcomes.
In a session at Asembia’s AXS23...
05/04/2023
First Report Managed Care

Decision-makers across the spectrum of managed care and the pharmacy supply chain gather to improve prescription medication access, affordability, and delivery.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use